🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well the combination of based decitabine an...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital, Southern Medical University,
Start Date
2021-12-01
Trial ID
NCT05376852
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of HQP1351 in patient...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2019-04-08
Trial ID
NCT03883100
Treatments Being Tested
This study is a Multi-center, Open-label Phase 1 Study to Determine the Rec...
Status
Recruiting
Location
Sun-Yat Sen University Cancer Center
Start Date
2018-07-11
Trial ID
NCT03594422
Treatments Being Tested
A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study ...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-02-05
Trial ID
NCT06423911
Treatments Being Tested
The purpose of this trial is to evaluate the efficacy and safety of olverem...
Status
Unknown
Location
Shenzhen Second People's Hospital
Start Date
2022-07-01
Trial ID
NCT05311943
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of HQP1351 in patient...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2019-04-08
Trial ID
NCT03883087
Treatments Being Tested
The objective of this study is to determine the mass balance and routes of ...
Status
Completed
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2019-11-19
Trial ID
NCT04126707
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics of HQP135...
Status
Completed
Location
Peking University People's Hospital
Start Date
2019-03-25
Trial ID
NCT03882281
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of HQP1351 in patient...
Status
Completed
Location
Peking University People's Hospital
Start Date
2019-10-21
Trial ID
NCT04126681
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) improves the...
Status
Withdrawn
Location
Department of Hematology, Nanfang Hospital, Southern Medical University,
Start Date
2022-01-01
Trial ID
NCT05604755
Treatments Being Tested